AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7039813
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy (B/A, BCG, NFT)
Trial: 3902388
Drug: Methylprednisolone (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (32 mg once daily)
Trial: 25803759
Drug: Ultrasound-guided lumbar
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided lumbar transforaminal epidural injection
Trial: 25803759
Drug: Fluoroscopy-controlled lumbar
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoroscopy-controlled lumbar transforaminal epidural injection
Trial: 15854634
Drug: Trilostane +
RxNorm normalized name: TRILOSTANE
DrugBank: Trilostane (DB01108)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trilostane + misoprostol (high-dose vaginal group: initial dose of 400 microg followed by 200 microg every 4 h)
Trial: 15854634
Drug: Trilostane +
RxNorm normalized name: TRILOSTANE
DrugBank: Trilostane (DB01108)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trilostane + misoprostol (vaginal-oral group: 400 microg vaginally followed by 200 microg orally every 4 h)
Trial: 7591314
Drug: Pre-hospital treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-hospital treatment with anistreplase followed by placebo after hospital admission (pre-hospital group; 2750 patients)
Trial: 2144914
Drug: Twice per
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice per week (2X/week, n = 23)
Trial: 7031861
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg bacampicillin twice daily
Trial: 7031861
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg bacampicillin
Trial: 7031861
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg bacampicillin
Trial: 22976566
Drug: Topical ozonated
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ozonated olive oil (OZO) as an adjunct to scaling and root planing (SRP)
Trial: 22976566
Drug: Topical chlorhexidine
RxNorm normalized name: chlorhexidine Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical chlorhexidine gel as a monotherapy
Trial: 17990196
Drug: EMDR treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR treatment (eight weekly sessions)
Trial: 17990196
Drug: EMDR treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR treatment
Trial: 15898028
Drug: Intravenous sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sufentanil (7.5 microg)
Trial: 28207505
Drug: EBCA (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBCA (esomeprazole and colloidal bismuth pectin with clarithromycin and amoxicillin)
Trial: 28207505
Drug: EBLA (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBLA (esomeprazole and colloidal bismuth pectin with levofloxacin and amoxicillin)
Trial: 28207505
Drug: ELA (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ELA (esomeprazole with levofloxacin and amoxicillin)
Trial: 26025562
Drug: Buspirone 15
RxNorm normalized name: busPIRone 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone 15 mg with melatonin-SR 3 mg
Trial: 10721538
Drug: Antibiotics (specifically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (specifically amoxycillin as first line treatment)
Trial: 9305231
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate 200 micrograms once daily
Trial: 9292184
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 200 micrograms once daily
Trial: 18356656
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of dexamethasone
Trial: 16554592
Drug: Intraluminal brachytherapy
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraluminal brachytherapy using iridium-192 with a dose of 14 Gy
Trial: 31394300
Drug: Adjunctive photodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive photodynamic therapy (PDT) with full-mouth disinfection (FMD)
Trial: 27798042
Drug: Prompt infertility
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prompt infertility treatment
Trial: 28486704
Drug: 6-month lifestyle
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month lifestyle intervention programme preceding infertility treatment
Trial: 25853229
Drug: Weekly motivational
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly motivational counseling
Trial: 19171726
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy (gastric banding surgery)
Trial: 8526243
Drug: Fluoxetine, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine, 20 mg/day for 5 weeks
Trial: 30670421
Drug: 100-mg levofloxacin
RxNorm normalized name: levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 100-mg levofloxacin dispersible tablets
Trial: 30670421
Drug: Adult (250-mg)
RxNorm normalized name: OC 8 Adult Acne
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adult (250-mg) levofloxacin tablets
Trial: 28794898
Drug: Angiotensin receptor
RxNorm normalized name: Angiotensin receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin receptor blockers (ARBs)
Trial: 8143996
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg, three times daily
Trial: 8143996
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg, three times daily
Trial: 8143996
Drug: Cisapride (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (both doses)
Trial: 12536700
Drug: Conventional medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medicine
Trial: 28328389
Drug: Tablet-based hearing
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tablet-based hearing screening method
Trial: 23885614
Drug: Moxibustion at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion at Shenshu (BL 23) and Guanyuan (CV 4) for 15 min once daily for 5 weeks after training.
Trial: 6363970
Drug: Peripheral anticholinergic
RxNorm normalized name: Anticholinergics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral anticholinergic therapy
Trial: 30094695
Drug: Cocaine users
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine users and injection drug users
Trial: 19337246
Drug: Esophageal capsule
RxNorm normalized name: Cellspan Esophageal Implant
DrugBank: Cellspan Esophageal Implant (DB18688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esophageal capsule endoscopy (ECE)
Trial: 17786387
Drug: Intravenous ATP
RxNorm normalized name: ATP
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ATP infusions at doses of 20 microg kg(‐1) min(‐1), 25-40 microg kg(‐1) min(‐1), and 45-50 microg kg(‐1) min(‐1)
Trial: 15612969
Drug: Purified trivalent
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified trivalent split-virus vaccine injections
Trial: 9853844
Drug: Recombinant follicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant follicle stimulating hormone (rFSH, Puregon)
Trial: 2904312
Drug: Prazosin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (5 mg every 8 hours)
Trial: 25161155
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg simvastatin
Trial: 27344670
Drug: PBM application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBM application using a 30 J/cm(2) dose
Trial: 15867169
Drug: Irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 300 mg/d
Trial: 16602839
Drug: mezlocillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mezlocillin (3 x 2 g/d)
Trial: 10913939
Drug: rhEPO (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPO (40 U/kg at a constant infusion rate for 30 min, starting 15 min before TRH injection)
Trial: 9044441
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement treatment
Trial: 4054198
Drug: Meclonazepam 1
RxNorm normalized name: clonazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meclonazepam 1 mg
Trial: 4054198
Drug: Meclonazepam 2
RxNorm normalized name: clonazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meclonazepam 2 mg
Trial: 4054198
Drug: Meclonazepam 4
RxNorm normalized name: clonazepam 0.4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meclonazepam 4 mg
Trial: 28068460
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment for 12 weeks
Trial: 8814098
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 700 mg/day
Trial: 8814098
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 600 mg/day
Trial: 8814098
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 500 mg/day
Trial: 28125598
Drug: No corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No corticosteroid therapy
Trial: 18410562
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus (strains E/N, Oxy and Pen) administered at 2 x 10(10) colony forming units, orally twice daily during antibiotic treatment
Trial: 12790964
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical injection sclerotherapy (Group 1)
Trial: 3875955
Drug: Maternal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal oxygen inhalation
Trial: 3875955
Drug: Oral long-term
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral long-term tocolysis
Trial: 29059389
Drug: IMB model-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMB model-based intervention plus nicotine replacement therapy
Trial: 25193393
Drug: Polypill (containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypill (containing aspirin 100 mg, simvastatin 40 mg, and ramipril 2.5, 5, or 10 mg)
Trial: 25193393
Drug: 3 drugs
RxNorm normalized name: goserelin
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3 drugs given separately (control group)
Trial: 22525485
Drug: Sublingual glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual glyceryl nitrate (GTN) 0.4 mg
Trial: 10192668
Drug: Topical anesthetics
RxNorm normalized name: topical anesthetics (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthetics and vasoconstrictors (phenylephrine 0.5%, 2% lidocaine jelly, 2% tetracaine, 14% benzocaine)
Trial: 7590720
Drug: Clindamycin 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 2% cream (5 grams daily for 3 days)
Trial: 91481
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g L-tryptophan
Trial: 31719084
Drug: Lifestyle Africa
RxNorm normalized name: African Pygeum extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle Africa intervention (17 weekly sessions delivered by trained community health workers, including text messaging and Motivational Interviewing training)
Trial: 21916989
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential therapy (20 mg rabeprazole and 1 g amoxicillin, twice daily for the first 5 days, followed by 20 mg rabeprazole, 500 mg clarithromycin, and 500 mg metronidazole, twice daily for the remaining 5 days)
Trial: 21916989
Drug: 7-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day triple therapy (20 mg rabeprazole, 500 mg clarithromycin, and 1 g amoxicillin, twice daily for 7 days)
Trial: 19533009
Drug: Both incontinence
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both incontinence pessary and behavioral therapy
Trial: 14970962
Drug: modified constraint-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified constraint-induced movement therapy (mCIMT)
Trial: 10373140
Drug: Omeprazole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (1 mg/kg/day or 2 mg/kg/day)
Trial: 7888256
Drug: Cold air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold air inhalation during exercise testing
Trial: 2091873
Drug: Genapol stabilized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genapol stabilized human insulin (HOE 21 PH H‐TRONIN)
Trial: 30914385
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (40 IU, 100 IU, 160 IU)
Trial: 17080879
Drug: Adper Prompt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adper Prompt L‐Pop (3M ESPE)
Trial: 31046700
Drug: PEG‐IFN alfa‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐IFN alfa‐2b 1.0 μg/kg/wk for 24 weeks
Trial: 31046700
Drug: PEG‐IFN alfa‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐IFN alfa‐2b 1.5 μg/kg/wk for 24 weeks
Trial: 28538361
Drug: CRP >150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRP >150 mg/L
Trial: 28538361
Drug: Duration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duration of antibiotic treatment
Trial: 7653482
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (500 mg/d)
Trial: 18800142
Drug: Conventional anti-hypertensive
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anti-hypertensive treatment
Trial: 7836707
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin, 4000 U daily SQ for 7-20 days
Trial: 30534176
Drug: Osteopathic visceral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic visceral manipulation (OVM); treatment group (OVMG)
Trial: 22720283
Drug: Converted implant‐retained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Converted implant‐retained overdenture (IOD)
Trial: 16331116
Drug: Felodipine extended
RxNorm normalized name: Felodipine Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine extended release 5 mg/day
Trial: 3046587
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin treatment (CIT)
Trial: 30780194
Drug: Half-dose clarithromycin
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Half-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 250 mg bid, bismuth potassium citrate 0.6 g bid) for 14 days
Trial: 25070960
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of Terutroban and Aspirin
Trial: 16217243
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E and Selenium (combination)
Trial: 9456279
Drug: sotalol, 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol, 120 mg daily (n = 93)
Trial: 9456279
Drug: metoprolol, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol, 75 mg daily (n = 98)
Trial: 27258204
Drug: Oral acetylsalicylic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetylsalicylic acid 100 mg per day after dinner
Trial: 22546942
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + PT (single session of adjunctive phototherapy)
Trial: 11082825
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal patch
Trial: 9439492
Drug: sICAM‐1 concentrations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sICAM‐1 concentrations in the highest quartile (> 260 ng/mL)
Trial: 2568824
Drug: Drug-free baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-free baseline
Trial: 357309
Drug: Controlled clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled clinical studies of antirheumatic and antianginal drugs
Trial: 26066705
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin pump therapy
Trial: 22487079
Drug: Daily insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily insulin requirements
Trial: 15892085
Drug: Adacolumn® treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adacolumn® treatment
Trial: 15892085
Drug: G-1 beads
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-1 beads (in vitro)
Trial: 1923397
Drug: Daily chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily chlorhexidine rinsing (0.12% solution)
Trial: 1923397
Drug: Weekly chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly chlorhexidine rinsing (0.12% solution)
Trial: 18815665
Drug: Amiodarone (AMD)
DrugBank: Amiodarone (DB01118)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amiodarone (AMD) treatment for more than 24 months
Trial: 10548998
Drug: Satisfaction with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satisfaction with psychopharmacological treatment
Trial: 8786016
Drug: ALA 1200
RxNorm normalized name: ALA
DrugBank: alpha-Linolenic acid (DB00132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA 1200 mg
Trial: 7044467
Drug: lipid-lowering therapy
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lipid-lowering therapy by diet and drugs
Trial: 25224684
Drug: Sonic nebulization
RxNorm normalized name: Ellis Tonic
DrugBank: Zinc sulfate, unspecified form (DB14548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonic nebulization (Pulmicort, 2 × 1 mg/4 mL)
Trial: 20859313
Drug: Cervical medial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical medial branch blocks with bupivacaine and steroid (Group II)
Trial: 7484858
Drug: Intravenous dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dofetilide at doses of 3.0 to 15.0 micrograms/kg
Trial: 7484858
Drug: Intravenous dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dofetilide at a dose of 1.5 micrograms/kg
Trial: 29987587
Drug: Bilateral botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral botulinum toxin (BT) therapy
Trial: 22733398
Drug: Triptorelin pamoate
RxNorm normalized name: Triptorelin Pamoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin pamoate (TP) at a dose of 11.5 mg at 3-month intervals until documented progression
Trial: 24030685
Drug: Milnacipran 100
RxNorm normalized name: milnacipran 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milnacipran 100 mg/day
Trial: 10515676
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol 50 mg twice weekly associated with cyclic medroxyprogesterone acetate 10 mg daily (n = 10)
Trial: 10515676
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg administered orally once a day (n = 11)
Trial: 9701421
Drug: levodropropizine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levodropropizine (75 mg t.i.d.; 7 days)
Trial: 9701421
Drug: dihydrocodeine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dihydrocodeine (10 mg t.i.d.; 7 days)
Trial: 26044701
Drug: Intra-arterial injection
RxNorm normalized name: METHOTREXATE 25 mg in 1 mL INTRA-ARTERIAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-arterial injection of autologous bone marrow mononuclear cells (2×10^6/kg or 5×10^6/kg)
Trial: 9506654
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg phenobarbital intravenously over 1 hour